- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Nutrition
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- PregTox
- The ReproPsych Group
- CAS Newsletter
National sponsor of the Motherisk Program
Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Sept.
5
2013
St. John's,NL
2013 FACE meeting
June
23
2013
Orlando, Florida
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting
.
-
Jul192012
-
Mar292012
-
Jul282011
-
Jan272011
- Read more in our News Archive
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
Consortium of Cancer in Pregnancy Evidence (CCoPE)
Dionne Laslo, BA, MA, PhD(candidate)
Ms. Laslo is a graduate of the University of Toronto. She completed her Masters in Clinical Child Psychology and is currently a doctoral student at the Institute of Medical Sciences of the University of Toronto. As a member of the Motherisk Team, Ms. Laslo is investigating neurodevelopment effects of in utero exposure to organic solvents. She has also conducted research in pediatric oncology, psychology and psychiatry. Ms. Laslo has published numerous articles and book chapters related to in utero exposure to various drugs and chemicals.
![[Valid RSS]](/images/rssValid.png "Validate my RSS feed")